NBIP-'1435

N/A

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameNBIP-'1435
Drug Alias NameNBIP-'1435NBIP-01435
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsAdrenal Hyperplasia, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAdrenal Hyperplasia, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A